PARK2 gene variants in Korean patients with Parkinson’s disease

[1]  D. Hoffman-Zacharska,et al.  Genomic instability in the PARK2 locus is associated with Parkinson’s disease , 2015, Journal of Applied Genetics.

[2]  G. Kozlov,et al.  Parkin structure and function , 2015, The FEBS journal.

[3]  Samuel Flores,et al.  Phosphorylation by PINK1 Releases the UBL Domain and Initializes the Conformational Opening of the E3 Ubiquitin Ligase Parkin , 2014, PLoS Comput. Biol..

[4]  M. Chu,et al.  Erratum: Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease , 2014, Journal of clinical neurology.

[5]  M. Chu,et al.  Analysis of Dosage Mutation in PARK2 among Korean Patients with Early-Onset or Familial Parkinson's Disease , 2014, Journal of clinical neurology.

[6]  E. Lai,et al.  Comparing clinical features of young onset, middle onset and late onset Parkinson's disease. , 2014, Parkinsonism & related disorders.

[7]  Wojciech Kozubski,et al.  Mutations in PRKN and SNCA Genes Important for the Progress of Parkinson’s Disease , 2013, Current genomics.

[8]  Ted M. Dawson,et al.  Parkin Plays a Role in Sporadic Parkinson's Disease , 2013, Neurodegenerative Diseases.

[9]  P. Mercier,et al.  A molecular explanation for the recessive nature of parkin-linked Parkinson’s disease , 2013, Nature Communications.

[10]  Norihiro Suzuki,et al.  Parkin-catalyzed Ubiquitin-Ester Transfer Is Triggered by PINK1-dependent Phosphorylation* , 2013, The Journal of Biological Chemistry.

[11]  Y. Kong,et al.  Accumulation of the parkin substrate, FAF1, plays a key role in the dopaminergic neurodegeneration. , 2013, Human molecular genetics.

[12]  M. Seong,et al.  Phase analysis identifies compound heterozygous deletions of the PARK2 gene in patients with early‐onset Parkinson disease , 2012, Clinical genetics.

[13]  Miratul M. K. Muqit,et al.  PINK1 is activated by mitochondrial membrane potential depolarization and stimulates Parkin E3 ligase activity by phosphorylating Serine 65 , 2012, Open Biology.

[14]  N. Hattori,et al.  PINK1 autophosphorylation upon membrane potential dissipation is essential for Parkin recruitment to damaged mitochondria , 2012, Nature Communications.

[15]  A. Brice,et al.  What genetics tells us about the causes and mechanisms of Parkinson's disease. , 2011, Physiological reviews.

[16]  J. Yun,et al.  Phenotype analysis in patients with early onset Parkinson’s disease with and without parkin mutations , 2011, Journal of Neurology.

[17]  K. Lim,et al.  Parkin Mediates Apparent E2-Independent Monoubiquitination In Vitro and Contains an Intrinsic Activity That Catalyzes Polyubiquitination , 2011, PloS one.

[18]  G. Schellenberg,et al.  A comprehensive analysis of deletions, multiplications, and copy number variations in PARK2 , 2010, Neurology.

[19]  K. Eguchi,et al.  A Single-Nucleotide Polymorphism of PARK2 Affects the Phenotype in Sporadic Parkinson Disease , 2010 .

[20]  O. Saucedo-Cárdenas,et al.  PARKIN-coding polymorphisms are not associated with Parkinson's disease in a population from northeastern Mexico , 2010, Neuroscience Letters.

[21]  P. Silburn,et al.  Screening PARK genes for mutations in early-onset Parkinson's disease patients from Queensland, Australia. , 2009, Parkinsonism & related disorders.

[22]  Y. Sohn,et al.  Analysis of PARK genes in a Korean cohort of early-onset Parkinson disease , 2008, Neurogenetics.

[23]  C. Mariani,et al.  Parkin analysis in early onset Parkinson's disease. , 2008, Parkinsonism & related disorders.

[24]  N. Bresolin,et al.  Parkin polymorphisms and environmental exposure: decrease in age at onset of Parkinson's disease. , 2007, Neurotoxicology.

[25]  A. Brice,et al.  Biochemical analysis of Parkinson's disease-causing variants of Parkin, an E3 ubiquitin-protein ligase with monoubiquitylation capacity. , 2006, Human molecular genetics.

[26]  N. Hattori,et al.  Diverse Effects of Pathogenic Mutations of Parkin That Catalyze Multiple Monoubiquitylation in Vitro* , 2006, Journal of Biological Chemistry.

[27]  N. Hattori,et al.  Geographic and ethnic differences in frequencies of two polymorphisms (D/N394 and L/I272) of the parkin gene in sporadic Parkinson's disease. , 2005, Parkinsonism & related disorders.

[28]  J. Perlmutter,et al.  Prevalence of parkin gene mutations and variations in idiopathic Parkinson's disease. , 2005, Parkinsonism & related disorders.

[29]  K. Lim,et al.  Familial-associated mutations differentially disrupt the solubility, localization, binding and ubiquitination properties of parkin. , 2005, Human molecular genetics.

[30]  K. Marder,et al.  Distribution, type, and origin of Parkin mutations: Review and case studies , 2004, Movement disorders : official journal of the Movement Disorder Society.

[31]  Y. Agid,et al.  Parkin mutations are frequent in patients with isolated early-onset parkinsonism. , 2003, Brain : a journal of neurology.

[32]  L. Seeberger,et al.  Heterozygosity for a mutation in the parkin gene leads to later onset Parkinson disease , 2003, Neurology.

[33]  Christine Klein,et al.  Role of parkin mutations in 111 community‐based patients with early‐onset parkinsonism , 2002, Annals of neurology.

[34]  A. Lang,et al.  The importance of gene dosage studies: mutational analysis of the parkin gene in early-onset parkinsonism. , 2001, Human molecular genetics.

[35]  A. Brookes,et al.  The parkin gene S/N167 polymorphism in Australian Parkinson's disease patients and controls. , 2001, Parkinsonism & related disorders.

[36]  S. Minoshima,et al.  Mutations in the parkin gene cause autosomal recessive juvenile parkinsonism , 1998, Nature.

[37]  C. Żekanowski,et al.  Integrated pathways of parkin control over mitochondrial maintenance - relevance to Parkinson's disease pathogenesis. , 2013, Acta neurobiologiae experimentalis.

[38]  T. Dawson,et al.  The role of parkin in familial and sporadic Parkinson's disease , 2010, Movement disorders : official journal of the Movement Disorder Society.